19 119919- ---ˇˆˇˆ ,, , 2016 19, 2016 192016 19: :::37 37 ... · 2016-02-21 · posted: feb 22...

19191919---- ISTISTISTIST, , , , 2016 192016 192016 192016 19::::37 37 37 37

& ,- 2 & ,- 2 & ,- 2 & ,- 2

() & -64 -82

,- 2 B - 2-

- G (,, -I , , K

L ) I 2 ,- & ()

- P 2 . . SI -

T . V - G

G V ()

B .. & Y

G - Z Y

. Y 2 \ - 2 2 ]

10 -G 2 2 30 G -

2 ^ 2 & ]

,- -64 \ - ,

Z ^ 2 \ _ --G

BY, YPY P

-82 b YG -

G & G G

*** ////1091109110911091

Ministry of Science & Technology 19-February-2016 18:16 IST

Agreement for Commercialisation of an Ayurvedic Formulation for Treatment of Malaria and

an Ayurvedic Formulation for Treatment of Diabetes

National Research Development Corporation (NRDC), an Enterprise of the Department of

Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi and

M/s Dabur India Ltd., New Delhi have entered into License Agreements for commercialization of

Ayush-64, an ayurvedic formulation for treatment of Malaria and Ayush-82, an ayurvedic

Formulation for management of Diabetes both developed by Central Council for Research in

Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous body of the Ministry of AYUSH

(Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy). The Licence agreements were

signed by Dr. H. Purushotham on behalf of National Research Development Corporation, New Delhi

and Dr. J. L. N. Sastry, Head Healthcare Research, on behalf of Dabur India Ltd., New Delhi at

NRDC Office in the presence of Sh. B.N. Sarkar, Scientist (F), Department of Scientific and Industrial

Research, New Delhi and Director, NRDC Board and other Senior executives of NRDC and Dabur.

The Agreements were exchanged in the presence of the Minister of State, Ministry of AYUSH, Shri

Shripad Yesso Naik and Secretary AYUSH, Shri Ajit M. Sharan, NRDC a Government Technology

Licensing Agency has so far licensed about 10 technologies developed by CCRAS to more than 30

companies in India.

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria which is one of the most

prevalent; destructive widely spread disease, well known to Ayurvedic Physicians as Visama Jvara

from ancient times. In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal

non-toxic drug has been developed by CCRAS after carrying out extensive pharmacological,

toxicological and Clinical studies. Ayush-82; an anti diabetic drug also developed by CCRAS is a combination of known and tested

hypoglycemic drugs.

The use of these two drugs would help millions of people suffering from Malaria and Diabetes. ******* KSP/ss (Release ID :136569)

OUR BUREAU

COMMENT (1) PRINT T+

NEW DELHI, FEBRUARY 21:

The National Research Development Corporation (NRDC), under the Ministry of Science &

Technology, and Dabur India have entered into licence agreements for commercialisation of

Ayush-64, an ayurvedic formulation for treatment of Malaria, and Ayush-82, an ayurvedic

formulation for management of diabetes. Both the formulations have been developed by

Central Council for Research in Ayurvedic Sciences, an autonomous body, and the Ministry

of AYUSH, an official release said.

The licence agreements were signed by H Purushotham on behalf of NRDCJ and LN Sastry,

Head, Healthcare Research, on behalf of Dabur India, it added.

(This article was published on February 21, 2016)

Posted: Feb 22 2016, 11:00 AM IST Mumbai

Dabur India has entered into License Agreements with the government for commercialization of malaria and diabetes drug Ayush 64 and Ayush 82 respectively. Ayush-64 is an ayurvedic formulation for treatment of Malaria and while Ayushfor management of diabetes. The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology and the company. Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.

Posted: Feb 22 2016, 11:00 AM IST Mumbai

India has entered into License Agreements with the government for commercialization of malaria and diabetes drug Ayush 64 and Ayush 82 respectively.

64 is an ayurvedic formulation for treatment of Malaria and while Ayush

The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology and the company.

India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.

India has entered into License Agreements with the government for commercialization of malaria and diabetes drug Ayush 64 and Ayush 82 respectively.

64 is an ayurvedic formulation for treatment of Malaria and while Ayush-82 is

The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial

India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.

By: FE Online | New Delhi | February 22, 2016 9:18 AM


Technology, and Dabur India have entered into license agreements for commercialization of



Central Council for Research in Ayurvedic Sciences, an autonomous body, and the Ministry

of AYUSH. The company has recently tied up with online marketplace Snapdeal to set up an

e-store for its ayurveda products called LiveVEDA.

Licence agreements for commercialisation of Ayush 64 & Ayush Press Trust of India | New Delhi February 20, 2016 Last Updated at 00:02 IST

The government today entered into License Agreements

and diabetes drug Ayush 64 and Ayush 82 respectively.

Ayush-64 is an ayurvedic formulation for treatment of Malaria and while Ayush

.

The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of

the Department of Scientific & Industrial Research, Ministry of Science & Technology and Dabur India Ltd.

The drugs Ayush 64 and Ayush 82 were developed by Central Council for Research in Ayurvedic

(CCRAS), New Delhi, an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga and naturopathy, Unani,

Siddha and Homeopathy).

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria.

In view of its wide prevalence and drug

developed by CCRAS after carrying out extensive pharmacological, toxicological and clinical studies.

Ayush-82 is a combination of known and tested hypoglycemic drugs.

Licence agreements for commercialisation of Ayush 64 & Ayush

February 20, 2016 Last Updated at 00:02 IST

The government today entered into License Agreements with Dabur India Ltd for commercialisation of malaria

64 and Ayush 82 respectively.

64 is an ayurvedic formulation for treatment of Malaria and while Ayush-82 is for management of diabetes.


epartment of Scientific & Industrial Research, Ministry of Science & Technology and Dabur India Ltd.

The drugs Ayush 64 and Ayush 82 were developed by Central Council for Research in Ayurvedic


64 is very effective for the treatment of Malaria.

In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic drug has been


82 is a combination of known and tested hypoglycemic drugs.

Ltd for commercialisation of malaria

82 is for management of diabetes.


epartment of Scientific & Industrial Research, Ministry of Science & Technology and Dabur India Ltd.

The drugs Ayush 64 and Ayush 82 were developed by Central Council for Research in Ayurvedic Sciences


toxic drug has been


Posted at: Feb 19 2016 10:42PM

image: http://www.uniindia.com/images/share_icon.jpg

Share

NRDC, Dabur sign agreement for commercialisation of Ayurvedic medicines

New Delhi, Feb 19 (UNI) Nat ional Research Devel opment Cor pora t ion ( NRDC) and M/s Dabur India Lt d, today enter ed into l i c ence agr eement for commerc ia l i sa t ion of an Ayur vedi c

for mula t ion for t r eatmen t of Malar ia and Diabetes .

' ' NRDC, an Enter pr is e of the Depar tment of Sc ient i f i c &

Science & Technology and M/s Dabur India Ltd, have enter ed into L icense Agr eements for

commer cia l is at i on of Ayush- 64, an ayur vedi c formul at ion for t r ea tment of Malar ia and

Ayush-82, an ayur vedi c For mulat ion for management

Counc i l for Research in Ayur vedic Sciences (CC RAS) , an Au tonomous body of the Minis t r y

of AYUSH ( Ayur veda , Yoga and na tur opathy, Unani , S iddha and Homeopathy) , ' ' an of f ic ia l

s ta temen t said her e.

The l i c ence agr eem ents wer e s i gned by Dr H Purushotham on behal f of Nat ional Resear ch

Devel opment C or pora t ion, and Dr J L N Sas tr y, Head Hea l thcar e Research, on behal f of

Dabur Ind ia Ltd, a t NRDC Office her e in the pr esence of BN Sar kar , Sc ient is t ( F) ,

Depar tment of Sc ient i f i c and Indus tr ia l Research and Dir ector , NRDC Board and other Senior execut ives of NRDC and Dabur .

The agr eem ents wer e exchanged in the pr esence of the Minis ter of Sta te for Ayush and Hea l th & Family Wel far e Shr ipad Yesso Na ik and Secr etar y AYUSH, Mr Aji t M

NRDC, a Gover nment Technology Licensi ng Agency, has so far l icensed about 10

technologies devel oped by CCRAS to m or e than 30 companies in India . The Ayur ved ic Dr ug

Ayush-64 is ver y ef fec t ive for the t r eat ment of Ma lar ia which is one of the most pr e

des truct i ve widely spr ead d i sease, wel l known to Ayur ved ic Phys ic ians as Visama Jvara fr om

ancient t imes .

In view of i t s wide pr evalence and drug r es i s tant malar ial paras i t e, a poly

drug has been developed by CCRAS af ter car r yi ng o

toxicologica l and c l in ical s tudies .

Ayush-82; an ant i d iabet ic drug a l so devel oped by CCRAS is a combina t ion of known and

tes ted hypogl ycemic dr ugs .

The use of these two dr ugs would help mil l ions of people suf fer ing from Malar

Diabetes . UNI NY AJ 2242

Posted at: Feb 19 2016 10:42PM

image: http://www.uniindia.com/images/share_icon.jpg


Nat ional Research Development Cor pora t ion ( NRDC) and M/s Dabur

India Ltd, t oday ent er ed int o l i cence agreement for commerc ia l i sa t ion of an Ayur ved i c

for mula t ion for t r ea tment of Malar ia and Diabetes.

' ' NRDC, an Enter pr is e of the Depar tmen t of Sc ient i f i c & I ndustr ia l Research, Minis t ry of

Sci ence & Technology and M/ s Dabur India Ltd, have enter ed into L icense Agr eem ents for

64 , an ayur vedic for mulat ion for t r ea tment of Malar ia and

82, an ayurvedic For mula t ion for management of Diabet es both developed by Cent ra l

Counci l for Research in Ayur vedic Sciences (CC RAS) , an Au tonomous body of the Minis t r y

of AYUSH ( Ayur veda , Yoga and natur opathy, Unani , S iddha and Homeopathy) , ' ' an of f ici a l

wer e s igned by Dr H P urushotham on behal f of Nat ional Research

Devel opment Corpora t ion , and Dr J L N Sast ry , Head Heal thcar e Research, on behal f of

Dabur India Ltd, a t NRDC Office her e in the pr esence of BN Sar kar , Sc ient is t ( F) ,

nd Indus tr ia l Research and Di rector , NRDC Board and other Senior

The agr eem ents were exchanged i n the pr esence of the Minis ter of Sta te for Ayush and Hea l th & Fami ly Wel far e Shr ipad Yesso Naik and Secr e tar y AYUSH, Mr Aji t M Sharan.

NRDC, a Gover nment Technology Licens ing Agency, has so far l icensed about 10

technologies devel oped by CCRAS to m or e than 30 companies in India . The Ayur vedi c Dr ug

64 is ver y e ffect ive for t he t r ea tment of Ma lar ia which is one of the most pr e

dest ruct ive wide ly spr ead d is ease, wel l known t o Ayur vedic Phys ic ians as Visama Jvara fr om

In view of i t s wide pr evalence and drug r es is tant malar ial paras i t e, a poly- her bal non

dr ug has been developed by CCRAS af ter car rying ou t extens ive pharmacologica l ,

tox icologica l and cl in ica l s tudi es .

82; an ant i d iabe t ic dr ug al so devel oped by CCRAS is a combina t ion of known and

The use of these two dr ugs would he lp mi l l ions of people suf fer ing fr om Malar

Nat ional Research Development Cor pora t i on ( NRDC) and M/s Dabur

India Ltd , today en ter ed int o l i cence agr eement for commerc ia l is at ion of an Ayurvedi c

I ndus tr i a l Research, Minis t r y of

Sc ience & Technology and M/ s Dabur India Ltd, have enter ed into License Agr eem ents for

64 , an ayur vedic for mul at ion for t reatment of Malar ia and

of Diabetes bot h devel oped by Centra l

Counci l for Research in Ayur vedic Sciences (CC RAS) , an Aut onomous body of the Minis t ry

of AYUSH ( Ayur veda , Yoga and natur opathy, Unani , S iddha and Homeopathy) , ' ' an off icia l

were s igned by Dr H P urushotham on behal f of Nat iona l Resear ch

Devel opment C or pora t ion, and Dr J L N Sastr y, Head Hea l thcar e Research, on behal f of

Dabur India Ltd, a t NRDC Office her e i n the pr esence of BN Sarkar , Sc ient i s t ( F) ,

nd Indus tr ia l Research and Dir ector , NRDC Boar d and other Seni or

The agr eem ents wer e exchanged i n the pr esence of the Minis ter of Sta te for Ayush and Heal th Sharan.

NRDC, a Government Technology Licens ing Agency, has so fa r l i censed about 10

t echnologies devel oped by CCRAS to m or e than 30 companies in I ndia . The Ayurvedic Drug

64 i s very e f fect ive for t he t r ea tment of Ma lar ia which is one of the mos t pr eva lent ;

des truct ive wide ly spr ead d is ease, wel l known to Ayur vedi c Phys icians as Visama Jvara fr om

her ba l non- toxic

u t ext ens ive phar macologica l ,

82; an ant i d iabe t ic dr ug al so devel oped by CCRAS is a combinat ion of known and

The use of these two dr ugs would he lp mil l ions of people suf fer ing fr om Malar ia and

Dabur to commercialise ayurvedic drugs for malaria, diabetic treatment

news

19 February 2016

National Research Development Corporation (NRDC) today signed an agreement with Dabur India

Ltd for commercialisation of two ayurvedic formulations, one for the treatment of malaria and the

other for diabetes treatment.

Under the agreement, NRDC will licence Ayush-64, an ayurvedic formulation for treatment of

Malaria and Ayush-82, an ayurvedic formulation for management of diabetes, both developed by

Central Council for Research in Ayurvedic Sciences (CCRAS), for commercial production, marketing

and distribution.

Ayush-64 has been found to be very effective for the treatment of malaria, which is one of the most

prevalent, destructive widely spread diseases. The ayurvedic formulation is well known to ayurvedic

physicians as `Visama Jvara' from ancient times for its wide prevalence and use against drug resistant

malarial parasite.

CCRAS has developed the poly-herbal non-toxic drug after carrying out extensive pharmacological,

toxicological and clinical studies, says an Ayush release.

Ayush-82, an anti-diabetic drug also developed by CCRAS, is a combination of known and tested

hypoglycemic drugs.

The use of these two drugs would help millions of people suffering from malaria and diabetes, the

release said.

National Research Development Corporation (NRDC) is an enterprise of the Department of Scientific

and Industrial Research of the ministry of science and technology and is engaged in technology

licensing, the agency has so far licensed about 10 technologies developed by CCRAS to more than 30

companies in India.

SATURDAY, FEBRUARY 20, 2016


COMMENTS PRINT

New Delhi | Friday, Feb 19 2016 IST

Nat ional Research Development Corpor a t ion ( NRDC) and M/s Dabur India L td, toda y enter ed int o

l ic ence agreement for commerc ia l is at ion of an A yur vedi c for mulat ion for t r ea tment of Malar ia and Diabetes.

' ' NRDC, an Enter pr is e of the Depar tment of Sc ient i f ic & Indus tr ial Resea rch, Minis t r y of Science

& Technology and M/s Dabur India Ltd, have en ter ed in to License Agr eem ents for

commerc ial isa t ion of Ayush- 64, an ayur vedic for mulat ion for t reatment of Malar ia and Ayush- 82,

an ayur vedic For mula t ion for management of Diabet es both devel oped by Central C ounci l for

Research in Ayur vedic Sciences (CCRAS) , an Aut onomous bod y of the Mini st r y of AYUSH

(Ayur veda , Yoga and na tur opa thy, Unani , S iddha and Hom eopa thy) , ' ' an of fi cia l s ta tement sa id

here .

The l icence agr eement s wer e s igned by Dr H Purushotham on behal f of Nat iona l Research

Devel opment Cor pora t i on , and Dr J L N Sas tr y, Head Hea l thcar e Research, on behal f of Dabur India

Ltd, a t NRDC Office her e in the presence of BN Sarkar , Sc ient is t (F) , Depar tmen t of Sc ient i f i c and Indus tr ia l Research and Dir ec tor , NRDC Boar d and other Sen ior execut ives of NRDC and Dabur .

The agr eem ents wer e exchanged in t he pr esence of the Minis t er of S ta te for Ayush and Hea l th & Family Wel far e Shr i pad Yesso Naik and Secr e tar y AYUSH, Mr Aj i t M Sharan .

NRDC, a Gover nment Technology Licens ing Agency, has so far l icensed about 10 technologi es

developed by CCRAS t o mor e t han 30 companies in I ndia . The Ayur vedic Dr ug Ayush-64 is ver y

ef fect ive for the t r ea tment of Malar ia which is one of the most pr eva lent ; destruc t ive wide ly spr ead dis ease , wel l known t o Ayur vedic Phys icians as Visama Jvara fr om ancient t imes.

In vi ew of i ts wide pr eva lence and dr ug r esis tant malar ia l paras i t e , a pol y- herba l non- toxic dr ug has

been develop ed by CCRAS af ter car r ying out extensi ve phar macol ogica l , toxicol ogica l and c l ini ca l

s tudies.

Ayush- 82; an ant i diabet ic drug a lso developed by CCRAS is a combinat i on of known and tes ted hypoglycemic drugs.

The use of these two dr ugs would help mil l ions of peopl e suffer ing fr om Malar ia and Diabetes . UNI NY AJ 2242

- - (UNI) - - C-1-1-DL0099-599189.Xml

New Delhi | Friday, Feb 19 2016 IST

Nat iona l Research Development Corporat ion (NRDC) and M/s Dabur Ind ia L td, today entered

into l icence agreement for commercia l isat ion of an Ayurvedic formulat ion for t rea tment of

Malar ia and Diabetes.

' ' NRDC, an Enterpr ise of the Depar tment of Scient i f i c & Industr ia l Research, Min istr y of

Science & Technology and M/s Dabur Ind ia L td, have entered into L icense Agreements for

commercia l isa t ion of Ayush-64, an ayurved ic formulat ion for t reatment of Ma lar ia and Ayush-

82, an ayurved ic Formulat ion for management of Diabetes both developed by Centra l

Counci l for Research in Ayurved ic Sciences (CCRAS), an Autonomous body o f the Min ist ry

of AYUSH (Ayurveda, Yoga and naturopathy, Unan i , S iddha and Homeopathy) , ' ' an of f ic ia l

statement sa id here.

The l i cence agreements were s igned by Dr H Purushotham on beha l f of Nat iona l Research

Deve lopment Corpora t ion, and Dr J L N Sastry, Head Heal thcare Research, on beha l f of

Dabur Ind ia Ltd, at NRDC Of f ice here in the presence of BN Sarkar , Scien t ist (F) ,

Depar tment of Scient i f ic and Industr ia l Research and Director , NRDC Board and other

Sen ior execut ives o f NRDC and Dabur .

The agreements were exchanged in the presence of the Minis ter o f State for Ayush and

Hea lth & Fami l y W elfare Shr ipad Yesso Na ik and Secretar y AYUSH, Mr Aj i t M Sharan.

NRDC, a Government Techno logy L icensing Agency, has so far l i censed about 10

techno log ies deve loped by CCRAS to more than 30 companies in Ind ia. The Ayurvedic Drug

Ayush-64 is very ef fect ive for the t reatment o f Malar ia which is one of the most preva lent ;

destruct ive wide ly spread d isease, we l l known to Ayurved ic Physic ians as Visama Jvara

f rom anc ien t t imes.

In v iew of i ts wide preva lence and drug res is tant malar ia l paras ite, a poly-herba l non- toxic

drug has been deve loped by CCRAS af ter car r ying out extensive pharmacolog ica l ,

toxico log ica l and c l inical stud ies.

Ayush-82; an ant i d iabet ic drug a lso deve loped by CCRAS is a combinat ion o f known and

tested hypog lycem ic drugs.

The use of these two drugs wou ld help m il l ions of peop le su f fer ing f rom Malar ia and

Diabetes.

& & & & -----G -G -G -G

-\, 20 () & () G -

-G ,- , 2 - - G G

2

e () & -64

-82 ,- 2 B -

2. -

2 . . Sf -

T . g V -

2 ^ 2 & ] ,-

-64 \ - , Z ^ 2

\ _ --G BY,

YPY P

-82 b -G -

G (,, -I, , K L)

f 2 ,- & () -

\

2 ^ 2 & ] ,-

64 \ -

--G

-82 b

G G

2 ^ 2 & ] ,-

- , Z ^ 2 \

-G BY, YPY P

b YG - G &

G G

2 ^ 2 & ] ,- -

^ 2 \ _

YPY P

G &

e ,- B e ,- B e ,- B e ,- B - - - - - - - -

Source: b -b -b -b - 19 Feb 2016 19:41:35

-\ -\ -\ -\, 19: e

() & -64 -82 ,-

2 B - 2- -

G

(,, -I, , K L) f 2 ,-

& () - j 2 . .

Sf - T . g V -

G G V () B

.. &k Y G - Z

Y . Y 2 \ - 2 2

] 10 -G 2 2 30 G -

2 ^ 2 & ] ,- -

64 \ - , Z ^ 2 \ _

--G BY, YPY P

-82 b YG - G &

G G

ECONOMY 20/02/2016 10:53 AM

Agreement for Commercialisation of an Ayurvedic Formulation for Treatment of Malaria and an

Ayurvedic Formulation for Treatment of Diabetes

National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial

Research, Ministry of Science & Technology, Govt. of India, New Delhi and M/s Dabur India, New Delhi have

entered into License Agreements for comme

Malaria and Ayush-82, an ayurvedic Formulation for management of Diabetes both developed by Central

Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous body of the

(Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy).

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria which is one of the most prevalent;

destructive widely spread disease, well known to Ayurvedic

view of its wide prevalence and drug resistant malarial parasite, a poly

developed by CCRAS after carrying out extensive pharmacological, toxicological and Clinical studies.

Ayush-82; an anti diabetic drug also developed by CCRAS is a combination of known and tested hypoglycemic

drugs.

The use of these two drugs would help millions of people suffering from Malaria and Diabetes.

Powered by Capital Market - Live News


Ayurvedic Formulation for Treatment of Diabetes



entered into License Agreements for commercialization of Ayush-64, an ayurvedic formulation for treatment of

82, an ayurvedic Formulation for management of Diabetes both developed by Central

Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous body of the Ministry of AYUSH

(Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy).

64 is very effective for the treatment of Malaria which is one of the most prevalent;

destructive widely spread disease, well known to Ayurvedic Physicians as Visama Jvara from ancient times. In

view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic drug has been


82; an anti diabetic drug also developed by CCRAS is a combination of known and tested hypoglycemic

The use of these two drugs would help millions of people suffering from Malaria and Diabetes.

Live News




64, an ayurvedic formulation for treatment of

82, an ayurvedic Formulation for management of Diabetes both developed by Central

Ministry of AYUSH

64 is very effective for the treatment of Malaria which is one of the most prevalent;

Physicians as Visama Jvara from ancient times. In

toxic drug has been


82; an anti diabetic drug also developed by CCRAS is a combination of known and tested hypoglycemic

Ayush-64 & Ayush-82 THE HANS INDIA | Feb 21,2016 , 04:42 AM IST

National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific &

Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi and M/s Dabur India Ltd.,

New Delhi have entered into License Agreements for commercialization of Ayush-64, an ayurvedic

formulation for treatment of Malaria and Ayush-82, an ayurvedic Formulation for management of Diabetes

both developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an

Autonomous body of the Ministry of AYUSH (Ayurveda, Yoga and naturopathy, Unani, Siddha and

Homeopathy). The Licence agreements were signed by Dr. H. Purushotham on behalf of National Research

Development Corporation, New Delhi and Dr.J.L.N.Sastry, Head Healthcare Research, on behalf of Dabur

India Ltd., New Delhi.

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria which is one of the most

prevalent; destructive widely spread disease, well known to Ayurvedic Physicians as Visama Jvara from

ancient times. In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic

drug has been developed by CCRAS after carrying out extensive pharmacological, toxicological and Clinical

studies. Each tablet of Ayush 64 contains: Saptaparna (Alstonia scholaris R. Br.) Bark Aqueous Extract 100

mg; Katuki (Picrorhiza kurroa Royle ex. Benth) Root do 100 mg; Kirata tikta (Swertia Chirata (Pexb ex.

Karst) Whole plant do 100 mg; and Kuberaksa (Caesalpinia crista Linn.) Seed powder 200 mg. The studies

revealed that Ayush- 64 in dose of 500 mg per kg of body weight for 12 weeks was considered safe and

non-toxic.

Ayush-82 contains: Karvella (Momordica charantia Linn.) seed 1 part; Jambu (Syzygium cumuni Linn.) seed

1 part; Amra (Mangifera indica Linn.) seed 1 part; and Gudmar (Gymnema sylvestre R. Br.) leaves 1 part.

Fine powder of these drugs was administered in the dose of 5 gm. TDS with 500 mg of pure Shilajita thrice

daily.

The study has been taken up on 805 patients in Councils Central Research Institute (Ayurveda), New Delhi

and other centres. The effect of treatment was assessed on fasting and postprandial blood sugar at various

stages of treatment, besides clinical evaluation.

The results indicate statistically significant reduction in fasting and post prandial blood sugar levels along

with clinical improvement. Good and fair control could be achieved in about 70% of patients. No toxic effects

were noted.


Posted On: 2016-02-19

Health & Lifestyle United News of India Newswire

New Delhi, Feb. 19 -- Nat ional Research Deve lopment Corporat ion (NRDC) and M/s Dabur India

Ltd, today entered into l icence agreement for commercia l isa t ion of an Ayurved ic formulat ion

for t rea tment of Malar ia and Diabetes.

' ' NRDC, an Enterpr ise of the Depar tment of Scient i f i c & Industr ia l Research, Min istr y of

Science & Technology and M/s Dabur Ind ia L td, have entered into L icense Agreements for

commercia l isa t ion of Ayush-64, an ayurved ic formulat ion for t reatment of Ma lar ia and Ayush-

82, an ayurved ic Formulat ion for management of Diabetes both developed by Centra l

Counci l for Research in Ayurved ic Sciences (CCRAS), an Autonomous body o f the Min ist ry

of AYUSH (Ayurveda, Yoga and naturopathy, Unan i , S iddha and Homeopathy) , ' ' an of f ic ia l

statement sa id here.

The l i cence agreements were s igned by Dr H Purushotham on beha l f of Nat iona l Research

Deve lopment Corpora t ion, and Dr J L N Sastry, Head Heal thcare Research, on beha l f of

Dabur Ind ia Ltd, at NRDC Of f ice here in the presence of BN Sarkar , Scien t ist (F) ,

Depar tment of Scient i f ic and Industr ia l Research and Director , NRDC Board and other

Sen ior execut ives o f NRDC and Dabur .

The agreements were exchanged in the presence of the Minis ter o f State for Ayush and

Hea lth & Fami l y W elfare Shr ipad Yesso Na ik and Secretar y AYUSH, Mr Aj i t M Sharan.

NRDC, a Government Techno logy L icensing Agency, has so far l i censed about 10

techno log ies deve loped by CCRAS to more than 30 companies in Ind ia. The Ayurvedic Drug

Ayush-64 is very ef fect ive for the t reatment o f Malar ia which is one of the most preva lent ;

destruct ive wide ly spread d isease, we l l known to Ayurved ic Physic ians as Visama Jvara

f rom anc ien t t imes.

In v iew of i ts wide preva lence and drug res is tant malar ia l paras ite, a poly-herba l non- toxic

drug has been deve loped by CCRAS af ter car r ying out extensive pharmacolog ica l ,

toxico log ica l and c l inical stud ies.

Ayush-82; an ant i d iabet ic drug a lso deve loped by CCRAS is a combinat ion o f known and

tested hypog lycem ic drugs.

The use of these two drugs wou ld help m il l ions of peop le su f fer ing f rom Malar ia and

Diabetes.

CURRENT AFFAIRS / CURRENT EVENTS

BY INSIGHTS FEBRUARY 20, 2016

Print PDF

Insights

Agreement for Commercialisation of Ayurvedic Formulations

National Research Development Corporation

Industrial Research, Ministry of Science

License Agreements for commercialization

1. Ayush-64, an ayurvedic formulation

very effective for the treatment

spread disease, well known to

of its wide prevalence and drug

developed by CCRAS after

studies.

2. Ayush-82, an ayurvedic Formulation

also developed by CCRAS is a

The use of these two drugs would

these medicines were developed by

New Delhi, an Autonomous body

Siddha and Homeopathy).

sources: pib.

EVENTS

FEBRUARY 20, 2016

Insights Daily Current Events, 20 February 2016


Corporation (NRDC), an Enterprise of the Department

Science & Technology and M/s Dabur India Ltd. have

commercialization of two Ayurvedic formulations.

formulation for treatment of Malaria. The Ayurvedic

treatment of Malaria which is one of the most prevalent;

to Ayurvedic Physicians as Visama Jvara from ancient

drug resistant malarial parasite, a poly-herbal non-

carrying out extensive pharmacological, toxicological

Formulation for management of Diabetes. Ayush-82; an

a combination of known and tested hypoglycemic

would help millions of people suffering from Malaria

by Central Council for Research in Ayurvedic Sciences (CCRAS)

of the Ministry of AYUSH (Ayurveda, Yoga and


Department of Scientific &

have entered into

Ayurvedic Drug Ayush-64 is

prevalent; destructive widely

ancient times. In view

-toxic drug has been

toxicological and Clinical

an anti diabetic drug

drugs.

Malaria and Diabetes. Both

Central Council for Research in Ayurvedic Sciences (CCRAS),

and naturopathy, Unani,

NRDC & ,- -

()

& -64 -82 ,- 2

B - 2- -

G (,, -I , , K L ) I

2 ,- & () - P 2

. . SI - T .

V -

G G V () B

.. & Y G - Z

Y . Y 2 \ - 2

2 ] 10 -G 2 2 30 G -

2 ^ 2 & ] ,- -

64 \ - , Z ^ 2 \ _

--G BY, YPY P

-82 b YG - G &

G G

Corporate News

Monday 22nd February 2016, 9:49 am


Technology, and Dabur India have entered into license agreements for commercialization of



Central Council for Research in Ayurvedic Sciences, an autonomous body, and the Ministry of

AYUSH. The company has recently tied up with online marketplace Snapdeal to set up an e-

store for its ayurveda products called 'LiveVEDA'.

19 119919- ---ˇˆˇˆ ,, , 2016 19, 2016 192016 19: :::37 37 ... · 2016-02-21 · posted: feb 22...

Documents